SOLUBLE INTERLEUKIN-2 RECEPTOR - ELEVATED LEVELS IN SERUM AND SYNOVIAL-FLUID OF PATIENTS WITH RHEUMATOID-ARTHRITIS

Soluble interleukin‐2 receptor (sIL‐2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the IL‐2R, was utilized for measurement. We found a striking elevation of sIL‐2R in RA SF as compared with DJD SF (RA, 1319 ± 135; DJD, 416 ± 59; p < 0.001). RA serum sIL‐2R levels were also significantly elevated over DJD levels. There was no interaction between rheumatoid factor (RF) and sIL‐2R. RA patients with elevated sIL‐2R levels had significantly longer disease duration, higher c‐reactive protein (CRP) levels in serum and SF, and higher RF levels in serum and SF. The groups were similar in regard to other laboratory variables. The presence of elevated levels of sIL‐2R in RA serum and SF confirms the presence of a heightened immune reactivity and in vivo activation of lymphocytes in RA. Copyright © 1990 Wiley Periodicals, Inc., A Wiley Company